Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Barusiban (INN; development code FE-200440) is a peptide drug which is among the most potent and selective oxytocin receptor antagonists known. It was trialed by Ferring Pharmaceuticals as a treatment of preterm labor but failed to demonstrate effectiveness and was not pursued any further.
The analysis highlights Overview, Related Topics and Entities as prominent areas in the source structure around Barusiban.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Barusiban shows recurring relationship patterns in the source. For example, Barusiban → Interactive image Another extracted example is Barusiban → None. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
oxytocin receptor drug code antagonist inn peptide antagonists trialed development fe-200440 among potent selective known ferring pharmaceuticals treatment preterm labor
TTTA extracted 10 structured relationships around Barusiban. Examples in this analysis include Barusiban → 3D model (JSmol) → Interactive image and Barusiban → ATC code → None. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Barusiban | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Barusiban | ATC code | None | 1.00 | infobox |
| Barusiban | CAS Number | 285571-64-4 | 1.00 | infobox |
| Barusiban | ChemSpider | 8008159 | 1.00 | infobox |
| Barusiban | CompTox Dashboard (EPA) | DTXSID20182771 | 1.00 | infobox |
| Barusiban | Drug class | Oxytocin receptor antagonist | 1.00 | infobox |
| Barusiban | Formula | C40H63N9O8S | 1.00 | infobox |
| Barusiban | Molar mass | 830.06 g·mol−1 | 1.00 | infobox |
| Barusiban | PubChem CID | 9832431 | 1.00 | infobox |
| Barusiban | UNII | UX33I93GLS | 1.00 | infobox |
The concept neighborhoods around Barusiban bring nearby vocabulary together. In this analysis, examples include Code, Drug and Oxytocin. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
Bridges highlight paths between different parts of the Barusiban map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Barusiban to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Overview, Related Topics & Entities, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Barusiban · EN edition · Analysis: TopicsToTalkAbout